SRSF2 Gene Mutation in Patients With t-MDS/AML

Clinical trial NCT03894852 · COMPLETED

Trial details

NCT number: NCT03894852
Sponsor: Zeinab Albadry Mohammed Zahran
Status: COMPLETED
Study type: OBSERVATIONAL

Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia

Start date: 2019-06-02
Primary completion: 2019-12-29
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.